| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K26531177 |
| PharmacoGx | BRD-K26531177 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MARK1 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | ADGRB3 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | FAM103A1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | CSDC2 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
| mRNA | CNOT9 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | DRC3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | TSSK4 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | ZNF771 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | KRTAP4-16 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | SNX30 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
